COVID-19 reinfection unlikely for at least 6 months: Study

COVID-19 reinfection unlikely for at least 6 months: Study

The spread of the coronavirus disease (COVID-19) in Mumbai
A man walks past a graffiti amid the spread of the coronavirus disease (COVID-19) in Mumbai, India, November 2, 2020. REUTERS/Francis Mascarenhas/Files

LONDON: People who have had COVID-19 are highly unlikely to contract it again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of fight against the coronavirus pandemic.

The findings should offer some reassurance for the more than 51 million people worldwide who have been infected with the pandemic disease, researchers at the University of Oxford said.

"This is really good news, because we can be confident that, at least in the short term, most people who get COVID-19 won’t get it again," said David Eyre, a professor at Oxford's Nuffield Department of Population Health, who co-led the study.

Isolated cases of reinfection with COVID-19, the disease caused by the SARS-CoV-2 virus, had raised concerns that immunity might be short-lived and that recovered patients may swiftly fall sick again.

But the results of this study, carried out in a cohort of UK healthcare workers - who are among those at highest risk of contracting COVID-19 - suggest cases of reinfection are likely to remain extremely rare.

READ: Hong Kong researchers report first documented COVID-19 reinfection

READ: Workers who have recovered from COVID-19 exempted from rostered routine testing: MOH, MOM

"Being infected with COVID-19 does offer protection against reinfection for most people for at least six months," Eyre said. "We found no new symptomatic infections in any of the participants who had tested positive for antibodies."

"This is really good news to see that we are seeing sustained levels of immune response in humans so far," Mike Ryan, WHO's top emergency expert, told a news conference. 

"It also gives us hope on the vaccine side."

Maria van Kerkhove, WHO's technical lead on COVID-19, said: "We still need to follow these individuals for a longer period of time to see how long immunity lasts."

The study, part of a major staff testing programme, covered a 30-week period between April and November 2020. Its results have not peer-reviewed by other scientists but were published before review on the MedRxiv website.

During the study, 89 of 11,052 staff without antibodies developed a new infection with symptoms, while none of the 1,246 staff with antibodies developed a symptomatic infection.

READ: WHO advises against remdesivir for COVID-19 treatment

Staff with antibodies were also less likely to test positive for COVID-19 without symptoms, the researchers said, with 76 without antibodies testing positive, compared to only three with antibodies. Those three were all well and did not develop COVID-19 symptoms, they added.

"We will continue to follow this cohort of staff carefully to see how long protection lasts and whether previous infection affects the severity of infection if people do get infected again," Eyre said.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Bookmark